Giza Dana Elena, Vasilescu Catalin, Calin George A
The University of Texas MD Anderson Cancer Center, Department of Experimental Therapeutics , Unit 1950, 1515 Holcombe Blvd, Houston, TX, 77030-4009 , USA +1 713 792 5461 ; +1 713 792 1204 ;
Expert Opin Biol Ther. 2014 Sep;14(9):1285-93. doi: 10.1517/14712598.2014.920812. Epub 2014 Jun 18.
A new concept of gene regulation, in which competitive endogenous RNAs (ceRNAs) compete for common microRNAs (miRNAs), suggests that mRNA targets have an active role as key elements in the regulation of miRNA availability within cells. ceRNAs are considered to be natural decoys of miRNA activity and can influence the expression of multiple miRNAs.
A new complex network of indirect interaction among the RNA transcripts competing for the same pool of miRNAs has been described; in this network, the nodes are the targets, and the links between the nodes are the miRNAs the targets have in common, which form smaller subnetworks. The incidence, state and severity of cancer can be evaluated on the basis of this network signature. The study of these new genome-scale regulatory networks involving miRNAs and ceRNAs may provide information that researchers can use to fine-tune these networks to improve responses to cancer therapy and/or develop new therapeutic interventions.
Combinational approaches based on complex regulatory ceRNA networks (ceRNETs) may be one of the most promising strategies for silencing important mediators of cancer-promoting pathways. Targeting a single miRNA may in fact represent a combined intervention that acts on the feedback and compensatory pathways that can impair treatment response or cause treatment resistance.
一种新的基因调控概念认为,竞争性内源RNA(ceRNA)会竞争共同的微小RNA(miRNA),这表明mRNA靶标作为细胞内miRNA可用性调控的关键元件发挥着积极作用。ceRNA被认为是miRNA活性的天然诱饵,能够影响多种miRNA的表达。
一种新的RNA转录本间间接相互作用的复杂网络已被描述,这些转录本竞争同一组miRNA;在该网络中,节点是靶标,节点间的连接是靶标共有的miRNA,它们形成较小的子网。癌症的发病率、状态和严重程度可基于此网络特征进行评估。对这些涉及miRNA和ceRNA的新型全基因组规模调控网络的研究,可能会为研究人员提供信息,使其能够微调这些网络以改善癌症治疗反应和/或开发新的治疗干预措施。
基于复杂调控ceRNA网络(ceRNET)的联合方法,可能是沉默癌症促进途径重要介质最具前景的策略之一。事实上,靶向单个miRNA可能代表一种联合干预,作用于可能损害治疗反应或导致治疗抗性的反馈和补偿途径。